Keywords: daiichi, pharma, 1st-qtr, downturn, smaller, expected, japan
Daiichi Pharma
Article | 23 August 2004
Japan's Daiichi Pharmaceuticals has reported a smaller-than-forecastdecline in revenues and earnings for the first quarter (April-June 2004) of the fiscal year ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
